Zepatier and Hair loss - a phase IV clinical study of FDA data

Summary:

Hair loss is reported as a side effect among people who take Zepatier (elbasvir; grazoprevir), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Naproxen, and have Hepatitis c.

The phase IV clinical study analyzes which people have Hair loss when taking Zepatier. It is created by eHealthMe based on reports of 4,481 people who have side effects when taking Zepatier from the FDA, and is updated regularly.

What is Zepatier?

Zepatier has active ingredients of elbasvir; grazoprevir. eHealthMe is studying from 4,482 Zepatier users. Check the latest studies of Zepatier.

What is Hair loss?

Hair loss is found to be associated with 2,411 drugs and 3,513 conditions by eHealthMe. Check the latest studies of Hair loss.

On Jul, 19, 2026

4,481 people reported to have side effects when taking Zepatier.
Among them, 42 people (0.94%) have Hair loss.

Among these 42 people:

How long have people been on Zepatier when they have Hair loss? *

What is the gender of people who have Hair loss when taking Zepatier? *

female: 87.5 %
male: 12.5 %

What is the age of people who have Hair loss when taking Zepatier? *

What are other drugs people take besides Zepatier? *

Acetaminophen: 3 people, 7.14%
Prednisone: 3 people, 7.14%
Phenylephrine Hydrochloride: 3 people, 7.14%
Pantoprazole Sodium: 3 people, 7.14%
Oxycodone Hydrochloride: 3 people, 7.14%
Celebrex: 3 people, 7.14%
Orencia: 3 people, 7.14%
Cetirizine Hydrochloride: 3 people, 7.14%
Cimzia: 3 people, 7.14%
Naproxen: 3 people, 7.14%

What are other side effects people have besides Hair loss? *

Fatigue (feeling of tiredness): 13 people, 30.95%
Headache (pain in head): 7 people, 16.67%
Nausea (feeling of having an urge to vomit): 6 people, 14.29%
Pain: 6 people, 14.29%
Insomnia (sleeplessness): 5 people, 11.90%
Weight Increased: 5 people, 11.90%
Itching: 5 people, 11.90%
Nausea And Vomiting: 4 people, 9.52%
Rashes (redness): 4 people, 9.52%
Diarrhea: 4 people, 9.52%

What are the existing conditions these people have? *

Hepatitis C: 17 people, 40.48%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 7.14%
Psoriasis (immune-mediated disease that affects the skin): 3 people, 7.14%
Stress And Anxiety: 2 people, 4.76%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 4.76%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 4.76%
Viral Load Decreased: 1 person, 2.38%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 1 person, 2.38%
Hepatocellular Carcinoma (liver cancer): 1 person, 2.38%
Hepatitis Viral: 1 person, 2.38%

* Approximation only. Some reports may have incomplete information.

Do you take Zepatier and have Hair loss?

- Check whether Hair loss is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zepatier:

Zepatier (4,482 reports)

Hair loss treatments and more:

Hair loss (271,201 reports)

Browse all side effects of Zepatier:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hair loss:

Hair loss (2,411 drugs)

Browse all the conditions that are associated with Hair loss:

Hair loss (3,513 conditions)

Related publications that referenced our studies

Lindsey SF, Tosti A, "Hair loss induced by tumor necrosis factor alpha inhibitors", J Clin Investigat Dermatol, 2015 Jan .
Lindsey SF, Tosti A, "Hair loss induced by tumor necrosis factor alpha inhibitors", J Clin Investigat Dermatol, 2015 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on elbasvir; grazoprevir (the active ingredients of Zepatier) and Zepatier (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.